Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prenatal Blood Typing With Next Generation Sequencing (NGS) - an Implementation Study of Red Cell Alloimmunization in Pregnancy

NCT07715214 is registered in ClinicalTrials.gov with Karolinska University Hospital as lead sponsor.

NCT NCT07715214
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07715214 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prenatal Blood Typing With Next Generation Sequencing (NGS) - an Implementation Study of Red Cell Alloimmunization in Pregnancy
Lead sponsor
Karolinska University Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
December 31, 2030
Enrollment
750 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hdfn, next generation sequencing (ngs), red blood cell alloimmunization in pregnancy